Braun Stacey Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.4M Buy
153,148
+4,292
+3% +$1,000K 1.24% 20
2025
Q4
$30.8M Buy
148,856
+13,411
+10% +$2.65M 1% 29
2025
Q3
$25.1M Buy
+135,445
New +$23.2M 0.82% 48
2025
Q2
Sell
-2,400
Closed -$398K 117
2025
Q1
$398K Sell
2,400
-180
-7% -$28.2K 0.02% 110
2024
Q4
$373K Hold
2,580
0.01% 109
2024
Q3
$418K Sell
2,580
-50
-2% -$7.97K 0.02% 107
2024
Q2
$384K Sell
2,630
-60
-2% -$8.92K 0.01% 112
2024
Q1
$426K Hold
2,690
0.02% 109
2023
Q4
$422K Sell
2,690
-35
-1% -$5.37K 0.02% 109
2023
Q3
$424K Sell
2,725
-153
-5% -$25.2K 0.02% 109
2023
Q2
$476K Sell
2,878
-21,616
-88% -$3.49M 0.02% 114
2023
Q1
$3.8M Sell
24,494
-101,873
-81% -$16.4M 0.1% 105
2022
Q4
$22.3M Sell
126,367
-2,410
-2% -$416K 1.27% 18
2022
Q3
$21M Sell
128,777
-2,793
-2% -$473K 1.28% 14
2022
Q2
$23.4M Sell
131,570
-272
-0.2% -$48.5K 1.33% 11
2022
Q1
$23.4M Sell
131,842
-1,012
-0.8% -$172K 0.97% 32
2021
Q4
$22.7M Sell
132,854
-8,103
-6% -$1.33M 0.83% 49
2021
Q3
$22.8M Sell
140,957
-3,116
-2% -$532K 0.91% 38
2021
Q2
$23.7M Sell
144,073
-10
-0% -$1.66K 0.92% 37
2021
Q1
$23.7M Sell
144,083
-1,772
-1% -$287K 1% 30
2020
Q4
$23M Buy
145,855
+12,191
+9% +$1.8M 1.03% 25
2020
Q3
$19.9M Buy
133,664
+885
+0.7% +$131K 1.06% 21
2020
Q2
$18.7M Buy
132,779
+27,088
+26% +$3.95M 1.08% 23
2020
Q1
$13.9M Sell
105,691
-10
-0% -$1.42K 1.06% 35
2019
Q4
$15.4M Buy
105,701
+5,520
+6% +$749K 0.86% 62
2019
Q3
$13M Sell
100,181
-5,163
-5% -$680K 0.82% 68
2019
Q2
$14.7M Sell
105,344
-6,143
-6% -$850K 0.94% 50
2019
Q1
$15.6M Buy
111,487
+670
+0.6% +$89.7K 1.04% 38
2018
Q4
$14.3M Sell
110,817
-10,292
-8% -$1.44M 1.13% 32
2018
Q3
$16.7M Buy
121,109
+300
+0.2% +$39.9K 1.07% 33
2018
Q2
$14.7M Sell
120,809
-6,075
-5% -$758K 0.99% 42
2018
Q1
$16.3M Sell
126,884
-6,506
-5% -$879K 1.12% 28
2017
Q4
$18.6M Sell
133,390
-5,097
-4% -$710K 1.25% 18
2017
Q3
$18M Sell
138,487
-10,977
-7% -$1.46M 1.23% 17
2017
Q2
$19.8M Sell
149,464
-10,476
-7% -$1.34M 1.28% 13
2017
Q1
$19.9M Sell
159,940
-7,230
-4% -$864K 1.26% 12
2016
Q4
$19.3M Sell
167,170
-1,989
-1% -$230K 1.27% 12
2016
Q3
$20M Buy
169,159
+689
+0.4% +$83.6K 1.27% 13
2016
Q2
$20.4M Sell
168,470
-14,197
-8% -$1.61M 1.32% 8
2016
Q1
$19.8M Sell
182,667
-15,485
-8% -$1.6M 1.29% 10
2015
Q4
$20.4M Buy
198,152
+15,466
+8% +$1.56M 1.28% 12
2015
Q3
$17.1M Sell
182,686
-70,865
-28% -$6.86M 1.14% 29
2015
Q2
$24.7M Buy
253,551
+65,520
+35% +$6.56M 1.05% 14
2015
Q1
$18.9M Sell
188,031
-4,722
-2% -$480K 1.11% 29
2014
Q4
$20.2M Sell
192,753
-3,115
-2% -$328K 1.23% 14
2014
Q3
$20.9M Sell
195,868
-3,120
-2% -$324K 1.29% 9
2014
Q2
$20.8M Sell
198,988
-3,265
-2% -$330K 1.24% 13
2014
Q1
$19.9M Sell
202,253
-7,675
-4% -$712K 1.16% 27
2013
Q4
$19.2M Sell
209,928
-6,097
-3% -$562K 1.1% 31
2013
Q3
$18.7M Sell
216,025
-3,930
-2% -$353K 1.15% 28
2013
Q2
$18.9M Buy
+219,955
New +$18.7M 1.19% 21

Other funds holding JNJ

Braun Stacey Associates's JNJ Position: Q1 2026 in Review

Braun Stacey Associates increased its Johnson & Johnson (JNJ) stake by 2.9% in Q1 2026, buying an estimated $1,000K and bringing the position to 153,148 shares worth $37.4M. The position accounts for 1.24% of the portfolio, ranked #20.

Braun Stacey Associates first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Braun Stacey Associates held 153,148 shares of Johnson & Johnson worth $37.4M as of Q1 2026.
  • Braun Stacey Associates bought 4,292 Johnson & Johnson shares in Q1 2026, an estimated $1,000K.
  • Johnson & Johnson made up 1.24% of Braun Stacey Associates's portfolio in Q1 2026, its #20 holding.
  • Braun Stacey Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.